Navigation Links
More Neurology Residents Using Clot-Busting Drug for Stroke

THURSDAY, Aug. 4 (HealthDay News) -- A growing number of neurology residents in the United States feel comfortable using the clot-busting drug tissue plasminogen activator (tPA) to treat stroke patients with acute ischemic stroke, a new study finds.

An ischemic stroke is caused by blocked blood flow to the brain.

Researchers found that the proportion of neurology residents who say they're comfortable using tPA rose from 73 percent in 2000 to 94 percent in 2010.

"This is good news," senior author Dr. Brett Cucchiara, an assistant professor of neurology at the Hospital of the University of Pennsylvania, Philadelphia, said in a journal news release.

"It is imperative that neurology residents attain a level of comfort using tPA that will allow them to use the medication effectively in their clinical practice and guide other physicians in its use," Cucchiara noted.

Even though there is evidence that administering tPA within 3 to 4.5 hours after a patient first experiences symptoms of an acute ischemic stroke can reduce disability caused by a stroke, less than 10 percent of these patients currently receive tPA treatment. Lack of physician confidence in using the treatment is one of the reasons for this low rate, according to the study.

The study also reported that 95 percent of 286 neurology residents who were surveyed in 2010 said they had used tPA, compared with 80 percent in an earlier survey. Of the 95 percent who had used tPA, 59 percent said they gave it to a patient at least once without direct faculty supervision.

The study is published in the current issue of the journal Stroke.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about stroke.

-- Robert Preidt

SOURCE: Stroke, news release, Aug. 4, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Neuralstem ALS trial in multiple presentations at upcoming American Academy of Neurology meeting
2. Projects In Knowledge Launches Free iPhone App of Living Medical Textbook Neurology: Parkinson's Disease Edition
3. Projects In Knowledge Launches Free iPhone App of Living Medical Textbook Neurology: Multiple Sclerosis 2010 Edition
4. Groundbreaking MS research to be presented at American Academy of Neurology Annual Meeting
5. Nursing home residents at heightened risk of falling in the days following
6. Ohio residents: Medical and health research important to states economy, jobs and incomes
7. Review Finds No Harm From Cutback in Residents Docs Hours
8. Psychological effects of BP oil spill go beyond residents of impacted shorelines
9. Most New Jersey residents see global health as critical to states economy
10. California Health Interview Survey releases newest data on state residents health
11. Web-based curriculum improves surgical residents knowledge of health care business
Post Your Comments:
Related Image:
More Neurology Residents Using Clot-Busting Drug for Stroke
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end ... Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... Ein neuer Kombinationsansatz vereint ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... Clinical Cancer Research vom 6. November ... vom 6. November 2015 berichtet. --> ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
Breaking Medicine Technology: